All Stories

  1. Therapeutic Potential of Polyphenols and their Nanoformulations in the Treatment of Colorectal Cancer

    Article • Anti-Cancer Agents in Medicinal Chemistry, November 2021, Bentham Science Publishers

    SHAHEER HASAN KHAN, Dr Masood A Khan

  2. Potential Implications of Black Seed and its Principal Constituent Thymoquinone in the Treatment of COVID-19 Patients

    Article • Current Pharmaceutical Biotechnology, July 2021, Bentham Science Publishers

    Dr Masood A Khan

  3. Thymoquinone Shows the Diverse Therapeutic Actions by Modulating Multiple Cell Signaling Pathways: Single Drug for Multiple Targets

    Article • Current Pharmaceutical Biotechnology, January 2019, Bentham Science Publishers

    Dr Masood A Khan

  4. Immune-Stimulatory and Therapeutic Activity of Tinospora cordifolia: Double-Edged Sword against Salmonellosis

    Article • Journal of Immunology Research, January 2017, Hindawi Publishing Corporation

    Dr Masood A Khan

  5. Combination of glycosphingosomes and liposomal doxorubicin shows increased activity against dimethyl-α-benzanthracene-induced fibrosarcoma in mice

    Article • International Journal of Nanomedicine, October 2015, Dove Medical Press

    Dr Masood A Khan, Dr Mohammad Suger Alorainy

  6. Liposomal thymoquinone effectively combats fluconazole-resistant Candida albicans in a murine model

    Article • International Journal of Biological Macromolecules, May 2015, Elsevier

    Dr Masood A Khan

  7. Coadministration of doxorubicin and etoposide loaded in camel milk phospholipids liposomes showed increased antitumor activity in a murine model

    Article • International Journal of Nanomedicine, April 2015, Taylor & Francis

    Dr Masood A Khan, Dr Mohammad Suger Alorainy, Dr Hamzah M Maswadeh, Dr ARSHAD HUSAIN RAHMANI

  8. Etoposide Incorporated into Camel Milk Phospholipids Liposomes Shows Increased Activity against Fibrosarcoma in a Mouse Model

    Article • BioMed Research International, January 2015, Hindawi Publishing Corporation

    Dr Masood A Khan, Dr Hamzah M Maswadeh

  9. Resveratrol suppresses the proliferation of breast cancer cells by inhibiting fatty acid synthase signaling pathway

    Article • Cancer Epidemiology, December 2014, Elsevier

    Dr Masood A Khan

  10. A structural study on the protection of glycation of superoxide dismutase by thymoquinone

    Article • International Journal of Biological Macromolecules, August 2014, Elsevier

    Dr Masood A Khan

  11. Protective effect of thymoquinone on glucose or methylglyoxal-induced glycation of superoxide dismutase

    Article • International Journal of Biological Macromolecules, April 2014, Elsevier

    Dr Masood A Khan

  12. Curcumin: A Potential Candidate in Prevention of Cancer via Modulation of Molecular Pathways

    Article • BioMed Research International, January 2014, Hindawi Publishing Corporation

    Dr Masood A Khan

  13. Therapeutic Implications of Black Seed and Its Constituent Thymoquinone in the Prevention of Cancer through Inactivation and Activation of Molecular Pathways

    Article • Evidence-based Complementary and Alternative Medicine, January 2014, Hindawi Publishing Corporation

    Dr Masood A Khan

  14. Forming a Complex with MHC Class I Molecules Interferes with Mouse CD1d Functional Expression

    Article • PLoS ONE, August 2013, PLOS

    Dr Masood A Khan

  15. Regulation of the Actin Cytoskeleton by Rho Kinase Controls Antigen Presentation by CD1d

    Article • The Journal of Immunology, July 2012, The American Association of Immunologists

    Dr Masood A Khan

  16. Immune stimulating and therapeutic potential of tuftsin-incorporated nystatin liposomes against Cryptococcus neoformans in leukopenic BALB/C mice

    Article • FEMS Immunology & Medical Microbiology, July 2012, Oxford University Press (OUP)

    Dr Masood A Khan

  17. Anthrax Lethal Toxin Impairs CD1d-Mediated Antigen Presentation by Targeting the Extracellular Signal-Related Kinase 1/2 Mitogen-Activated Protein Kinase Pathway

    Article • Infection and Immunity, March 2010, ASM Journals

    Dr Masood A Khan

  18. Statins Impair CD1d-Mediated Antigen Presentation through the Inhibition of Prenylation

    Article • The Journal of Immunology, April 2009, The American Association of Immunologists

    Dr Masood A Khan

  19. Vesicular Stomatitis Virus Matrix Protein Impairs CD1d-Mediated Antigen Presentation through Activation of the p38 MAPK Pathway

    Article • Journal of Virology, September 2008, ASM Journals

    Dr Masood A Khan

  20. Apoptosis-induced inhibition of CD1d-mediated antigen presentation: different roles for caspases and signal transduction pathways

    Article • Immunology, September 2008, Wiley

    Dr Masood A Khan

  21. Type I NKT cells protect (and type II NKT cells suppress) the host's innate antitumor immune response to a B-cell lymphoma

    Article • Blood, April 2008, American Society of Hematology

    Dr Masood A Khan

  22. Protein kinase C δ is a critical regulator of CD1d-mediated antigen presentation

    Article • European Journal of Immunology, September 2007, Wiley

    Dr Masood A Khan

  23. Thermal Destabilization of Stem Bromelain by Trehalose

    Article • Journal of Protein Chemistry, January 2007, Springer Science + Business Media

    Dr Masood A Khan

  24. Inhibition of CD1d1-mediated antigen presentation by the vaccinia virus B1R and H5R molecules

    Article • European Journal of Immunology, October 2006, Wiley

    Dr Masood A Khan

  25. Toxicity, stability and pharmacokinetics of amphotericin B in immunomodulator tuftsin-bearing liposomes in a murine model

    Article • Journal of Antimicrobial Chemotherapy, May 2006, Oxford University Press (OUP)

    Dr Masood A Khan

  26. Prophylactic use of liposomized tuftsin enhances the susceptibility of Candida albicans to fluconazole in leukopenic mice

    Article • FEMS Immunology & Medical Microbiology, February 2006, Oxford University Press (OUP)

    Dr Masood A Khan

  27. Enhanced efficacy of pH-sensitive nystatin liposomes against Cryptococcus neoformans in murine model

    Article • Journal of Antimicrobial Chemotherapy, January 2006, Oxford University Press (OUP)

    Dr Masood A Khan

  28. Safety, efficacy and pharmacokinetics of tuftsin-loaded nystatin liposomes in murine model

    Article • Journal of Drug Targeting, January 2006, Taylor & Francis

    Dr Masood A Khan

  29. Antimicrobial activity of clove oil and its potential in the treatment of vaginal candidiasis

    Article • Journal of Drug Targeting, October 2005, Taylor & Francis

    Dr Masood A Khan

  30. Virus-Induced Inhibition of CD1d1-Mediated Antigen Presentation: Reciprocal Regulation by p38 and ERK

    Article • The Journal of Immunology, September 2005, The American Association of Immunologists

    Dr Masood A Khan

  31. Immunomodulator tuftsin increases the susceptibility ofCryptococcus neoformansto liposomal amphotericin B in immunocompetent BALB/c mice

    Article • Journal of Drug Targeting, August 2005, Taylor & Francis

    Dr Masood A Khan

  32. Incorporation of amphotericin B in tuftsin-bearing liposomes showed enhanced efficacy against systemic cryptococcosis in leucopenic mice

    Article • Journal of Antimicrobial Chemotherapy, July 2005, Oxford University Press (OUP)

    Dr Masood A Khan

  33. Tuftsin-mediated immunoprophylaxis against an isolate of Aspergillus fumigatus shows less in vivo susceptibility to amphotericin B

    Article • FEMS Immunology & Medical Microbiology, June 2005, Oxford University Press (OUP)

    Dr Masood A Khan

  34. Enhanced anticryptococcal activity of chloroquine in phosphatidylserine-containing liposomes in a murine model

    Article • Journal of Antimicrobial Chemotherapy, January 2005, Oxford University Press (OUP)

    Dr Masood A Khan

  35. Prophylactic Role of Liposomized Chloroquine Against Murine Cryptococcosis Less Susceptible to Fluconazole

    Article • Pharmaceutical Research, December 2004, Springer Science + Business Media

    Dr Masood A Khan

  36. Prophylactic Role of Immunomodulators in Treatment of Systemic Candidiasis in Leukopenic Mice

    Article • Journal of Drug Targeting, August 2004, Taylor & Francis

    Dr Masood A Khan

  37. Co-administration of immunomodulator tuftsin and liposomised nystatin can combat less susceptibleCandida albicansinfection in temporarily neutropenic mice

    Article • FEMS Immunology & Medical Microbiology, July 2004, Oxford University Press (OUP)

    Dr Masood A Khan

  38. Liposome‐Bilirubin Interaction: A Novel Strategy to Eliminate Bilirubin from Systemic Circulation

    Article • Journal of Liposome Research, January 2004, Taylor & Francis

    Dr Masood A Khan

  39. Antigen entrapped in the escheriosomes leads to the generation of CD4+ helper and CD8+ cytotoxic T cell response

    Article • Vaccine, June 2003, Elsevier

    Dr Masood A Khan

  40. Use of Tuftsin Bearing Nystatin Liposomes against an Isolate of Candida albicans showing Less In Vivo Susceptibility to Amphotericin B

    Article • Journal of Drug Targeting, January 2003, Taylor & Francis

    Dr Masood A Khan

  41. Binding of bilirubin with albumin-coupled liposomes: implications in the treatment of jaundice

    Article • Biochimica et Biophysica Acta (BBA) - Biomembranes, August 2002, Elsevier

    Dr Masood A Khan

  42. Immunomodulator Tuftsin Augments Anti-fungal Activity of Amphotericin B Against Experimental Murine Candidiasis

    Article • Journal of Drug Targeting, January 2002, Taylor & Francis

    Dr Masood A Khan

  43. Fusogenic potential of prokaryotic membrane lipids.

    Article • European Journal of Biochemistry, November 2001, Wiley

    Dr Masood A Khan

  44. Use of Liposomes as an Immunopotentiating Delivery System: in Perspective of Vaccine Development

    Article • Scandinavian Journal of Immunology, July 2001, Wiley

    Dr Masood A Khan

  45. Liposome Mediated Antigen Delivery Leads to Induction of CD8+ T Lymphocyte and Antibody Responses against the V3 Loop Region of HIV gp120

    Article • Cellular Immunology, May 2001, Elsevier

    Dr Masood A Khan